BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beyranvand Nejad E, Labrie C, van Elsas MJ, Kleinovink JW, Mittrücker HW, Franken KLMC, Heink S, Korn T, Arens R, van Hall T, van der Burg SH. IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors. J Immunother Cancer 2021;9:e002460. [PMID: 33879600 DOI: 10.1136/jitc-2021-002460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Korn T, Hiltensperger M. Role of IL-6 in the commitment of T cell subsets. Cytokine 2021;146:155654. [PMID: 34325116 DOI: 10.1016/j.cyto.2021.155654] [Reference Citation Analysis]
2 Xiao X, Peng Y, Wang Z, Zhang L, Yang T, Sun Y, Chen Y, Zhang W, Chang X, Huang W, Tian S, Feng Z, Xinhua N, Tang Q, Mao Y. A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME. Pharmacol Res 2022;:106269. [PMID: 35605813 DOI: 10.1016/j.phrs.2022.106269] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]